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airborne.cam: a risk calculator of SARS-CoV-2 aerosol




airborne.cam helps users understand how their surroundings and day-to-day behaviour can
be adapted in order to minimise the risk of indoors transmission of the SARS-CoV-2 virus.
The app is based on the well-mixed approach to calculate the individual risk of infection based
on the exposure time of a healthy, susceptible individual to infectious long-suspended viral
particles indoors. This approach considers that individuals are far apart from each other, that
is, there is no risk of short-range transmission either by large or small droplets/aerosols, nor
by contact with contaminated surfaces. The basic user can change inputs such as ventilation
rate, type of face covering, number of occupants, and type of activity to assess their impact on
risk of infection, while more advanced features are available for the user familiar with science
concerning aerosol transmission.
1 Intended use and main assumptions
The World Health Organization (WHO) and the most recent studies [1, 2, 3, 4, 5] consider the
following as the most likely transmission routes of the SARS-CoV-2 virus:
• fomite transmission, that is, transmission through contact with contaminated surfaces;
• droplet transmission, caused by large droplets carrying the virus, exhaled in respiratory
releases as coughing, sneezing, or simply by breathing and speaking;
• aerosol transmission, caused by small exhaled respiratory droplets/particles carrying the
virus.
Differently from large droplets that are quickly deposited on surfaces after being exhaled, aerosols
are fine particles that can remain suspended over long periods of time in the air. Aerosol trans-
mission, as acknowledged by the WHO, “can occur in specific settings, particularly in indoor,
crowded and inadequately ventilated spaces, where infected person(s) spend long periods of time
with others, such as restaurants, choir practices, fitness classes, nightclubs, offices and/or places
of worship.” [1]
Washing hands, wearing face coverings, and respecting a safe physical distancing between each
other are effective measures we can take to suppress fomite and droplet transmission [1]. Aerosols,
if contaminated with a pathogen, are a hazard to susceptible individuals from the moment they
are emitted by a sick individual [6, 7]. Due to their small size, aerosols follow the motion of air
currents, and can accumulate indoors if ventilation is poor [3]. In addition, aerosols are not 100%
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filtered by simple, cotton face coverings. Still, a series of actions can be taken to reduce risk of
transmission indoors, such as improving ventilation, reducing exposure time in a contaminated
setting and, most importantly, using masks that have a high efficiency in filtering aerosol, thus
reducing both the amount of aerosol exhaled by a sick individual as well as the amount inhaled by
a susceptible one. These factors, as well as others, are assessed in this app.
airborne.cam estimates the risk of infection for a single individual considering only aerosol
transmission due to accumulation of infectious viral particles in a specific indoor room with a spe-
cific activity, as set by the user. This does not mean that the other transmission routes mentioned
are not relevant in an indoor context; rather, they are simply not accounted for in this approach.
To put it simply, the user should consider that, on top of the risk estimates given by airborne.cam,
there are additional risks related to exposure to contaminated surfaces and due to short-distance
transmission through droplets/aerosol. Therefore, the results given by the app should be used as
a way to understand how different parameters affect the transmission of the SARS-CoV-2 virus in
this setting, and should not be used as a definitive or absolute evaluation of risk.
To account for the effects of ventilation, which can mitigate contamination risk from aerosols [8],
a well-mixed approach is employed. This approach considers ventilation scenarios where a ”mixing
ventilation” strategy is used. Thus, our model considers that mixing between viral particles and
air occurs faster than the purging times of a given ventilation system and hence the viral particles
are homogeneously dispersed in the room. This may not be the case for every situation, but may
often be a fair approximation.1
The transmission of the SARS-CoV-2 virus is a topic of active research. Hence, the uncertainties
involved in the present calculation are high2, which prevents the results given by this app from
being used as an absolute quantification of risk of infection in a determined setting. The user
should not consider that the indicated risk by the app is a precise quantification of the probability
of being infected.
The objective of the app is to help the user achieve a better understanding on the potential
risk reductions by taking specific actions, such as wearing a particular type of mask, increase
ventilation rate, or reduce exposure time. Moreover, airborne.cam should be used as a guide, so
that users understand aerosol transmission as a function of their surroundings, interpreting which
situations can pose a potential risk, but always keeping into consideration the guidelines issued by
Authorities or the building manager (e.g., social distancing, use of masks). Needless to say, the
app is not a substitute for a professional assessment of ventilation or of disease transmission risk
for a given indoor scenario.
We hope that the use of airborne.cam can improve the general knowledge on the importance
of ventilation in reducing the risk of SARS-CoV-2 transmission through aerosols indoors and can
help occupants and managers of indoor spaces make informed choices on risk mitigation measures.
1Typically, ventilation patterns can create inhomogeneities in a room, that is, pockets of air that can have a high
or a low concentration of viral particles. The well-mixed approximation is typically acceptable in situations where
recirculating air systems (e.g., A/C, fans with closed windows etc.) and low “air changes per hour” (ACH) are used.
In other settings, the air mixture is not uniform and emissions/virus concentration may vary spatially, being higher
near the infected person and lower away from them.
2For more information on the knowns and unknowns of the COVID-19 disease and the SARS-CoV-2 virus which
affect the current modelling approach, the user is referred to the website compiled by researchers of the UK Centre
for Doctoral Training in Aerosol Sciences, who summarised the recent scientific findings related to COVID-19 in
https://aerosol-soc.com/covid-19/. Additionally, Royal Society’s Rapid Assistance in Modelling the Pandemic
(RAMP) initiative, Task 7, have been updating a ventilation guide aiming at minimising the transmission of the
virus, with focus on winter conditions (see https://arxiv.org/abs/2009.12781).
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2 Using the app
2.1 Setting-up an indoors scenario
In this Section, the various parameters that are input by the user are described. The Basic Mode
needs information on occupancy, activity, face covering type, and ventilation rate, and these are
sufficient to produce an estimate of the risk to an average healthy individual as a function of
exposure time. The app uses many more parameters, whose numerical values come from the
literature. In the Advanced Mode, greater customisation is possible, and the presence of air
purifiers is also included.
Basic Mode
Under room, the user specifies the total floor area (in square metres) and ceiling height (metres)
of the room being analysed. Next, under duration, the time duration of the event being analysed
is set based on a given opening and closing time of the room set by the user. This defines the
duration of the event, given in the horizontal axis of all plots of the interface. Here, it is important
to note that the opening time should be set from the moment the room is first used. In other
words, the room must be empty for a sufficiently long time before opening, so that it always starts
with “clean” air.
Then, ventilation settings are defined by the user. This is set in terms of air changes per hour
(ACH). For example, for a room with a volume of 100 m3, a ventilation rate of 1 ACH means that
100 m3 (or 100,000 litres) of outside air are brought in every hour. The app automatically calculates
the equivalent in litres per second per person (l/s/person) based on the maximum occupancy set by
the user for the room. Some countries have specific ventilation legislation for buildings, which are
typically given in terms of l/s/person. Ventilation rates are usually defined based on those values
for specific scenarios (office buildings, schools, hospitals), resulting in an absolute ventilation rate
given in terms of ACH. Although typical values found in domestic, office, and hospital settings are
given as reference values, the user also has the option of setting a custom ACH numerical value.3
Next, occupancy settings are defined. Maximum occupancy is given in terms of number of
people. A constant, maximum occupancy is then assumed for the duration of the entire event.
Alternatively, variable occupancy can also be set in the advanced mode, discussed further below.
The user also specifies if susceptible individuals are using a mask (and if so, what type of mask),
as well as the type of activity being carried out in the room.
Finally, details about the infectious/sick individuals in the room are defined. Either a constant
number of individuals is set or a relative value (%). If the latter is set, the absolute number of
infectious individuals is calculated by the app based on the number of occupants in the room at a
given instant. The relative, percent value of infectious individuals may be particularly useful in a
scenario of variable occupancy – this can be set in the advanced mode. Finally, the user can also
define a mask for the infectious occupants as well as the type of activity they are carrying out.
3In spaces where forced ventilation systems are in use, the ventilation rate in air changes per hour is a parameter
predefined for that particular system. However, in naturally ventilated settings, where windows are opened so
outside air will flow into the room, it might be slightly more complicated to estimate an ACH value. For now, before
this is implemented as a feature built into the app, the user is referred to section 4.1 of the WHO Natural ventilation
guide (https://www.who.int/water_sanitation_health/publications/natural_ventilation/en/) to estimate the
ACH in naturally ventilated spaces.
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Advanced Mode
In addition to the settings above, there is an advanced mode, which allows for more customisa-
tion. First, in the basic mode, it is assumed that the viral load – the concentration of viable virus
in the saliva of sick individuals – is the same, and equal to 109 copies per ml. In the advanced
mode, two other values can be set for reference. The number of viral particles in the aerosol is
probably the greatest source of uncertainty in the present calculations.
The advanced mode also allows the user to define a different size for the maximum particles
carried by ventilation – this is commonly referred to as the aerosol cut-off size. This is understood to
vary between 5-100 micrometres – stronger ventilation currents will be able to carry larger particles.
There is also an option to set a vertical velocity of the air flows, which could be found in particular
ventilation scenarios. Additionally, the user can the ventilation flow rate as a combination of
outside air brought in and indoors air filtered and recirculated (not necessarily at 100% efficiency).
Common filter settings are given based on the ISO 16890. These features of the advanced mode
may be helpful to the ventilation expert.
Finally, the advanced mode also allows for variable occupancy. Currently, this is based on a
Gaussian function with predetermined settings. We hope to make this parameter more flexible in
the future, so that more detailed information (e.g., Google maps “popular times” feature) can be
used as an input. The user can also define evenly-spaced breaks throughout the day by using the
regular breaks mode.
2.2 Application examples
Example 1: Classroom and ACH
Consider a room with 100 m2 floor area and 3 m ceiling height, occupied for 2 hours by 20 people.
If only one of the occupants is infected, nobody is using masks and typical building ventilation
with 3 ACH are in place, the risk of infection would evolve in time as shown by the curve in Fig. 1,
leading to an estimated risk of infection of about 19% after 2 hours. If, however, the ACH is
increased, the risk of infection would be reduced to 8.8% with ACH = 3, about 6% with ACH =
5, and 3.5% with ACH = 10. These results show the importance of a correct level of ventilation
to minimise the estimated risk of infection.
Example 2: Classroom and mask usage
Consider the same room and occupancy scenario as in Example 1. Again, if only one of the
occupants is infected, no occupants are using masks, and typical building ventilation with 3 ACH
are in place, the risk of infection would evolve in time as shown by the respective curve in Fig. 1,
leading to an estimated risk of infection of 8.8% after 2 hours. If, however, the occupants are using
masks, the risk of infection will be reduced according to the type of masks used. The estimated
risk becomes 3.8% if 1-ply cloth masks are used (Fig. 2), 2.2% if 3-ply cloth masks are used, 1.5%
if surgical masks are used and 0.09% if FFP2/N95 masks are used. These results highlight not
only the impact mask usage has on mitigating risk of transmission, but also how effective each
mask type is for the given conditions.
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Figure 1: Evolution in time of infection risk for a room with 100 m2 surface and 3 m height,
occupied for 2 hours by 20 people, one of them infected, none with masks and ventilated with
different “air changes per hour” (ACH).
Figure 2: Evolution in time of infection risk for a room with 100 m2 surface and 3 m height,
ventilated with 3 ACH and occupied for 2 hours by 20 people, one of them infected and (a) none
with masks, (b) all using 1-ply cloth masks, (c) all using 3-ply cloth masks, (d) all using surgical
masks and (e) all using FFP2/N95 masks.
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3 Scientific basis
The scientific basis of this app is given in detail in Ref. [5]. Here a few additions are made
to improve the usability of the various models explained below.
3.1 Equations of mass balance
Here a well-mixed condition is assumed, that is, that long suspended viral particles exhaled by an
infectious person and air mix quickly, faster than the purging times of a given ventilation system.
This way, a mass balance equation can be derived to find the temporal evolution of the particle
concentration, C, within the room with volume V . Note that here we use the units PFU/m3 to
denote the concentration of viable viral particles, or viral copies in the air4 (see section 3.4 for








λ+ κ+ v + s
)
C, (1)
where ninf the number of infected people within the room wearing a mask with capture efficiency
ηmask and generating Ṅv,gen viral particles per unit of time emitted by continuous exhalation while
speaking. During the same time of emission, the virus from aerosols is being removed via viral
decay, λ, the settling of the aerosol droplets, κ, and ventilation, v. The ventilation rate can be
expressed as v = Q/V = ACH with Q being the supply of outside air to the room and ACH
the equivalent “air changes per hour”. A sterilisation rate can also be included in the removal
mechanisms and here it is denoted as s. Equation (1) is a first-order linear ordinary differential
equation which can be integrated over a time period [t0; t] to give
C(t) =
ninf · (1 − ηmask) · Ṅv,gen




ninf · (1 − ηmask) · Ṅv,gen








Equation (2) is directly implemented in the app and various parameters can be changed, as de-
scribed in section 2.1. When ninf > 0, i.e., when at least one infected person is present in the room,
there is a competition between the generation of particles and their removal by ventilation, gravity
and viral decay. For a given room volume and ventilation rate, the most crucial parameter is the
total generation rate of viral particles which depends on multiple other parameters, explained in
more detail later. When the infected occupants leave the room, there is a time delay until the
viral particle concentration levels become negligible and safe. This time delay depends on the total
removal rate and is dictated by a simplified version of Eq. 2 given by
C(t) = C(t0) exp
(
− (λ+ κ+ v + s)(t− t0)
)
. (3)
In the following, more details regarding the parameters Ṅv,gen, ηmask, λ, κ and s are provided.
4Plaque forming units (PFU) are a virology metric that quantifies the amount (not the total number) able to
cause infection. Knowledge of the total PFU inhaled by a person allows for the calculation of the risk via an infection
dose model such as the one in Ref. [9].
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3.2 Exhalation of viral particles
As explained in Refs. [10, 11], humans produce droplet and aerosol particles by expiratory activities:
breathing, speaking, coughing or sneezing. Infectious pathogens, such as SARS-CoV-2, might be
be carried by these particles, remaining viable for a long time before removed by ventilation or
gravity. The total amount of particles suspended in the air can be calculated using (i) parameters
for the initial size, type and composition of particles as emitted by a human, (ii) estimates for
the initial amount of virus found in the sputum of an infected person, and (iii) physical models
for the physical transformation of these particles, e.g., via evaporation, and their movement in a
room. Such calculations have been performed for a range of scenarios in a comprehensive study in
Ref. [5]. More calculations are planned for the future.
Estimation of aerosol generation rate
When relying on Eqs. 1–2 to calculate the amount of infectious particles (viable viral copies), the
generation rate, Ṅv,gen, should correspond to the amount of aerosol, i.e., the particles that can
remain suspended for long times and can follow the motion of air flows within a room, being capable
to “mix” with the air. This is only a fraction of the particles emitted from the mouth, since larger
droplets tend to settle on surfaces shortly after emission. The relative difference depends on a
number of factors such as ambient conditions, flow conditions, droplet composition, and the initial
(exhaled) particle size distribution. As discussed in Ref. [5], these factors can be incorporated into
the generation rate using some assumptions5. Typical values for the generation rate are given in
Table 1, where Ṅv,gen is expressed as a function of upward air velocity, assumed cut-off diameter for
aerosol and viral load in the sputum of the infected person(s). The upward air velocity is relevant
for some scenarios, e.g., low-speed displacement ventilation, where upward air streams could delay
the settling of particles and consequently increase the concentration of suspended particles. The
generation rate is here considered to be also a function of the cut-off diameter for aerosol, that is
the size threshold below which all particles are considered small enough to follow the flow, thus
being removed by ventilation. Although the Stokes number of a particle or droplet, i.e., the ratio
of its characteristic time scale to the flow time scale, is generally used to evaluate how these move
in relation to air flows, an arbitrary size of 5—10 µm is often used to define aerosol particles [12].
Recent findings suggest that higher values should be used instead [12, 13]. In general, there is
significant uncertainty in this area and it is not quite proper to assume a predefined cut-off value.
This is something we aim to address in the future.
Effect of viral load
Despite the significant uncertainty regarding the concentration of suspended aerosol particles within
the room, the highest uncertainty regarding the total amount of virus in the air lies with the initial
viral load, Vl, found in the sputum of the infected person(s). The amount of virus depends on the
progress of the disease. Measurements of RNA copies of virus in sputum show values ranging from
104 to 1010 viral copies/ml, while higher values have also been observed [6, 14, 15]. Additional
uncertainty concerning that parameter exists simply because, until the present moment, no studies
have been able to quantify the amount of viable viral copies in droplets/aerosol samples. Thus,
5In future work, we aim to improve the estimation Ṅv,gen and modify Eqs. 1–2 so that Ṅv,gen can be calculated
without ambiguity. This would necessitate a formulation that considers all droplet sizes and not only aerosol
particles.
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Table 1: Values for the generation rate, Ṅv,gen, depending on conditions of upward air velocity,
assumed cut-off diameter for the aerosol particles and the viral load, Vl, at the sputum of the
infected person. The exhalation gas flow rate is considered equal to 0.211 l/s (considering sedentary
activity), whereas ambient temperature and humidity are considered equal to 20◦C and 40%,
respectively. The composition of droplets are assumed to be that of low-protein sputum following
Ref. [5].
Upward air Aerosol cut-off Ṅv,gen (PFU/s)
velocity diameter
(m/s) (µm) Vl = 10
8 copies/ml Vl = 10
9 copies/ml Vl = 10
10 copies/ml
0 5 0.045 0.453 4.527
0 10 0.048 0.484 4.843
0 20 0.059 0.589 5.890
0 40 0.512 5.115 51.15
0 100 1.622 16.22 162.2
0.1 5 0.047 0.473 4.728
0.1 10 0.051 0.506 5.058
0.1 20 0.065 0.647 6.470
0.1 40 0.870 8.700 86.97
0.1 100 3.007 30.07 300.7
although the initial viable viral load might be lower than the values reported, here we consider a
range that might be understood as a worst-case scenario condition.
Effect of activity
The activity of the infected person(s) may also be considered and Ṅv,gen can be scaled accordingly
to account for the change in the exhaled flow. Assuming sedentary activity (see option “sitting
speaking”), one may consult Table 1, whereas for the option “standing/exercise” and “heavy
exercise” these values are scaled by 2.5 and 6.1, respectively, following estimations in Ref. [7].
Effect of masks and face coverings
The mask efficiency, ηmask, appearing in Eqs. 1–2 has been considered to be constant with values
taken from Ref. [16]. More specifically, the mask efficiency has been taken equal to 90% when a
FFP2/N95 mask6 is worn by the infected person(s), 59% when a surgical mask is used, and 51%
and 35% for 3-ply and 1-ply cloth face coverings, respectively. In reality, these values can vary
depending on the manufacturing quality but also on how well they are worn. We aim to update
these efficiencies in the future and also modify the mask efficiency to be conditional on the emitted
droplet particle size as more knowledge is gained on this area.
3.3 Removal by ventilation, sterilisation, viral decay and gravity
While a room is occupied by an infected individual or not, the virus in suspended aerosols is
constantly removed by ventilation, viral decay and gravity but also sterilisation if an independent
filter or air cleaner unit has been installed.
6Although nominal efficiency values are typically around 95% for FFP2 and N95 masks, we consider a lower
value due to potential leaks in poor-fitted masks or simply long-term use.
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Ventilation
For ventilation, the total “air changes per hour” (ACH) dictates the ventilation removal rate, v,
found in Eqs. 1–3. The ventilation should, however, only refer to the outside air brought in by
ventilation. Other air flow rates, e.g., brought in by recirculation, should be distinguished and this








where Q the air flow rate coming from outside air (brought in by ventilation), also corresponding to
a fraction xoutside of the total air flow rate supplied to the room, denoted as Qtot. If the advanced
mode is selected, it is possible to modify xoutside, otherwise all the air supply is thought to originate
from outside air (xoutside = 100%).
Sterilisation
Sterilisation is possible through air cleaners, such as UV cleaners or photocatalytic oxidation, or
air filters (see Ref. [8] for more information). When the advanced mode is activated in the app, it
is possible to see the effect of various air filter types which are widely used in heating, ventilation
and air-conditioning applications for buildings. The sterilisation (filtration) rate achieved by an
air filter may be given by




The rate, s, is proportional to the amount of air passing through the filter, (1 − xoutside)Qtot,
which in practice is achieved via recirculation of room air, initially filled with aerosols and then
(partially) sterilised. Filters are also characterised by a sterilisation (filtration) efficiency, ηs, which
is dependent on the particle sizes to be filtered. The exact size of aerosols in the room depends on
a number of conditions which have also been described in Section 3.2. Aerosols from respiratory
events do not have a unique size but they follow a particle size distribution (PSD) which has been
pre-calculated in Ref. [5] for a range of conditions. The knowledge of the PSD allows the estimation
of the amount of virus in various size ranges for which the filtration efficiency is known. Currently,
the app supports only a few air filter types:
• HEPA: a filter with ηs = 99.95% of particles that are 0.3 microns in diameter according to
the European Standard EN 1822-1:2009.
• ePM1 (90%): a filter with ηs = 90% in particles 0.3 micron to 1 micron in size (PM1)
according to the ISO 16890-1:2016 standard.
• ePM2.5 (90%): a filter with ηs = 90% in particles 0.3 micron to 2.5 micron in size (PM2.5)
according to the ISO 16890-1:2016 standard.
• ePM10 (90%): a filter with ηs = 90% in particles 0.3 micron to 10 micron in size (PM10)
according to the ISO 16890-1:2016 standard.
• ISO coarse: a filter with ηs < 50% efficiency (here taken equal to 40%) in PM10 according
to the ISO 16890-1:2016 standard.
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Viral decay
As far as viral decay is concerned, we model it assuming an exponential decay at a constant rate
λ = 0.636 h−1 that applies equally to all droplet sizes and compositions. This value was obtained
from experiments [17] which verified the stability of the SARS-CoV-2 virus on aerosols.
Gravity
Settling of aerosols by gravity is smaller compared to viral decay. For the suspended aerosol
resulting from speaking, Ref. [5] showed that removal by gravity started only after 20 min and
stabilised at settling rate of κ = 0.39 h−1 after 30 min of emission. Here we consider the same
value for κ and we retain it constant throughout the calculation of Eqs. 1–2.
3.4 Inhalation of viral particles and infection risk
Total amount of virus inhaled
Let us now consider an healthy susceptible individual present in the given room filled with sus-
pended viral particles. The total number of viral particles (copies), Nvirus, that will be inhaled
over a time period [t0; t] is given by
Nvirus(t) = Nvirus(t0) + (1 − ηmask) ·
∫ t
t0
C(t) ·Qinh · dt (6)
where Qinh is an inhalation rate, ηmask a mask efficiency and Nvirus(t0) is the total amount of virus
inhaled until t = t0. Equation 6 is not solved for the whole time duration selected in the app
but only when the room is filled. When a room is empty, e.g., during a break, then Nvirus stays
constant and the inhaled dose is updated only when the occupant enters the room again. Since a
well-mixed approach is employed, the concentration, C, is considered uniform and the location of
the occupants does not matter.
Effect of activity
A parameter here is the inhalation rate which may be taken equal to 0.521 l/s for an average
person [18], assuming sedentary activity (see option “sitting speaking”). When the option “stand-
ing/exercise” and “heavy exercise” are selected in the app, the inhalation rate is scaled by 2.5 and
6.1, respectively.
Effect of masks and face coverings
The mask efficiency for inhalation, ηmask, appearing in Eq. 6 has been considered to be constant
and equal to what assumed for exhalation (following Ref. [16]).
Calculation of infection risk
As discussed previously, the total amount of viral particles is normally reported as the amount of
plaque forming units (PFU) which will result in a given percent of illness over X% of a popula-
tion [5]. In the lack of these values for SARS-CoV-2, we used the infection dose model by Ref. [9]
where risk of infection, Prisk, for a viral dose equal to Nvirus is given by
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where kp = 4.1 × 102 was obtained from a model developed for SARS-CoV-1. This was used due
to the claimed similarity of this virus with SARS-CoV-2 and as it is in the same genetic group as
other coronaviruses such as HCoV-229E (human common cold), MHV-S and HEV-67N (animal
coronaviruses) for which the model also demonstrated a good agreement with experimental data [9].
3.5 CO2 concentration
The concentration of CO2 may be calculated in a similar way as to Eqs. 1–2 by removing the mask
efficiency (gaseous emission is not affected by mask use), the removal via sterilisation, viral decay



















whereas for an empty room, it will read





In Eq. 8, np stands for the total number of people in the room and Q̇CO2 stands for an exhalation
rate of CO2. Here, Q̇CO2 is based on the model in Ref. [19] for an average adult having 1.8 m
2
surface area and metabolic activity equal to 1.15 met when seated (sedentary activity, see option
“sitting speaking”). This corresponds to Q̇CO2 = 0.005 l/s. When the option “standing/exercise”
or “heavy exercise” is selected in the app, the metabolic rate changes to 1.3 and 3.8, respectively.
Note that Q̇CO2 in Ref. [19] scales linearly with the metabolic rate.
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